Disease Development Suppliers In Asia Middle East

GI Innovation is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and ...

Emosis develops and provides physicians with first-in-class, on demand, and user-friendly extended in vitro diagnostic products, centered on lab assay kits to be routinely performed on the rapidly growing new generation of flow cytometers, including ...

Located in Wuhan, Hubei Province, China, Dimed Laser Technology Co., Ltd. is one of the most professional manufacturers and suppliers of medical laser systems engaged in surgical and therapy laser equipment R&D, marketing, sales and services. After ...

Parijat is a three decades old Indian MNC with extensive global presence in 70 countries, 6 international offices, exclusive distribution networks in India, Russia and C.I.S and West Africa. The Parijat group of companies offers international ...

Established in 1989, Jafron Biomedical (ChiNext: JFSW) is a global provider of technology, product and therapy service in the hemoadsorption industry. With a market value of $7 billion, Jafron has three branches, 11 subsidiaries, one sub-subsidiary ...

Concept Medical is driving innovation in medical devices, with a focus on developing technologies for drug delivery with a strong emphasis on intellectual property. Based in Tampa, Florida; Concept Medical has always striven to find solutions to ...

Since KogeneBiotech was founded in 2000, and our company has earned a reputation for innovation in Molecular Diagnostics. Our main business units are the production of Real-time PCR/conventional assay based on the active R&D works and testing ...

MD Healthcare contributes to being healthy through innovative healthcare solutions based on cutting edge science and technology. One of the most revolutionary advances in the biological sciences in recent years has been the realization that ...

LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...